1. Home
  2. ATEN vs CDNA Comparison

ATEN vs CDNA Comparison

Compare ATEN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

N/A

Current Price

$18.08

Market Cap

1.3B

Sector

Technology

ML Signal

N/A

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$19.49

Market Cap

712.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATEN
CDNA
Founded
2004
1998
Country
United States
United States
Employees
481
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
712.2M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
ATEN
CDNA
Price
$18.08
$19.49
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$21.50
$26.67
AVG Volume (30 Days)
650.4K
818.6K
Earning Date
02-03-2026
11-04-2025
Dividend Yield
1.33%
N/A
EPS Growth
4.68
N/A
EPS
0.69
1.22
Revenue
$284,406,000.00
$357,998,000.00
Revenue This Year
$12.37
$14.11
Revenue Next Year
$8.10
$12.00
P/E Ratio
$26.07
$15.93
Revenue Growth
10.27
14.46
52 Week Low
$13.81
$10.96
52 Week High
$21.90
$25.95

Technical Indicators

Market Signals
Indicator
ATEN
CDNA
Relative Strength Index (RSI) 57.43 61.51
Support Level $17.42 $19.21
Resistance Level $18.65 $20.92
Average True Range (ATR) 0.35 0.88
MACD 0.07 0.03
Stochastic Oscillator 65.58 63.52

Price Performance

Historical Comparison
ATEN
CDNA

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: